iShares Genomics Immunology and Healthcare ETF
Filed by iShares Trust. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| TWSTTwist Bioscience Corp | 4.79% | $9.1M |
| REGNRegeneron Pharmaceuticals Inc | 4.35% | $8.3M |
| INCYIncyte Corp | 4.23% | $8.1M |
| MRNAModerna Inc | 4.19% | $8M |
| MRKMerck & Co Inc | 3.91% | $7.5M |
| VRTXVertex Pharmaceuticals Inc | 3.87% | $7.4M |
| BNTXBiontech SE | 3.73% | $7.1M |
| EXELExelixis Inc | 3.65% | $7M |
| IBRXImmunitybio Inc | 3.07% | $5.9M |
| NVAXNovavax Inc | 1.30% | $2.5M |
| KURAKura Oncology Inc | 0.88% | $1.7M |
| NTLAIntellia Therapeutics Inc | 0.51% | $981.4K |
| OCGNOcugen Inc | 0.47% | $890.3K |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow iShares Genomics Immunology and Healthcare ETF by email
iShares Genomics Immunology and Healthcare ETF's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.